PCSK9: a target for hypercholesterolaemia in nephrotic syndrome

被引:6
|
作者
Alan W. J. Morris
机构
关键词
D O I
10.1038/nrneph.2016.111
中图分类号
学科分类号
摘要
引用
收藏
页码:510 / 510
相关论文
共 50 条
  • [1] Inhibition of PCSK9 in familial hypercholesterolaemia
    Sijbrands, Eric J. G.
    LANCET, 2012, 380 (9836): : 6 - 7
  • [2] Familial hypercholesterolaemia: PCSK9 inhibitors are coming
    Santos, Raul D.
    Watts, Gerald F.
    LANCET, 2015, 385 (9965): : 307 - 310
  • [3] PCSK9 inhibition in children with familial hypercholesterolaemia
    Hegele, Robert A.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (10): : 686 - 688
  • [4] PCSK9 inhibitors for treating familial hypercholesterolaemia
    Hiroshi Mabuchi
    Atsushi Nohara
    Nature Reviews Endocrinology, 2015, 11 : 8 - 9
  • [5] PCSK9 INHIBITORS ARE EFFICIENT IN TREATMENT OF RESISTANT HYPERCHOLESTEROLEMIA IN NEPHROTIC SYNDROME
    Brinar, Ivana Vukovic
    Ivandic, Ema
    Gellineo, Lana
    Jelakovic, Ana
    Prlic, Margareta Fistrek
    Jelakovic, Bojan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I167 - I167
  • [6] PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia
    Wu, Huaizhu
    Ballantyne, Christie M.
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (07) : 385 - +
  • [7] THERAPY PCSK9 inhibitors for treating familial hypercholesterolaemia
    Mabuchi, Hiroshi
    Nohara, Atsushi
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (01) : 8 - 9
  • [8] PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia
    Huaizhu Wu
    Christie M. Ballantyne
    Nature Reviews Cardiology, 2017, 14 : 385 - 386
  • [9] Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
    Jatem, Elias
    Lima, Joan
    Montoro, Bruno
    Torres-Bondia, Francisco
    Segarra, Alfons
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (01): : 101 - 109
  • [10] PCSK9: a new target for hypercholesterolemia
    Cariou, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 16 - 16